Cabazitaxel - Wikipedia

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U ...

Cabazitaxel - Informazioni sui farmaci

Proprietà farmacologiche. Cabazitaxel è un nuovo taxano registrato tramite procedura centralizzata europea nel trattamento dei pazienti con carcinoma metastatico ...

Cabazitaxel - VIDAL - La base de données en ligne des ...

Cabazitaxel : mécanisme d'action, cas d'usage, interactions possibles, prise en charge, médicaments

Cabazitaxel - Drug Information - Chemocare

Cabazitaxel (Jevtana) chemotherapy side effects, how it's given, how it works, precautions and self care tips for treatment of metastatic prostate cancer

JEVTANA® (cabazitaxel) Injection for Advanced Prostate ...

Learn about JEVTANA, a NCCN designated category 1 second-line therapy for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated ...

For the Patient Cabazitaxel injection - BC Cancer

For the Patient: Cabazitaxel injection : Other names: JEVTANA® • Cabazitaxel (ka baz I tax’ el) is a drug that is used to treat some types of cancer.

Medikamente - Jevtana® (Cabazitaxel) - KISP - Hilfe bei ...

Ralf schrieb am 29.4.2010: Die US-amerikanische Zulassungsbehörde FDA sagt ein beschleunigtes Zulassungsverfahren für das neue Chemotherapeutikum Cabazitaxel zur ...

Overview | Cabazitaxel for hormone-relapsed metastatic ...

Evidence-based recommendations on cabazitaxel (Jevtana) for prostate cancer that has come back after it was treated with docetaxel

Jevtana - Summary of Product Characteristics (SmPC) - (eMC)

One ml of concentrate contains 40 mg cabazitaxel. Each vial of 1.5 ml (nominal volume) of concentrate contains 60 mg cabazitaxel. After initial dilution with the ...

Why JEVTANA® (cabazitaxel) Injection?

See why JEVTANA for advanced prostate cancer may be able to help. Hear from Larry & Joyce and their experience with JEVTANA. See risks & benefits.